IAN T CLARK
CIK 1336504 · Board of Director · last filed 2026-08-05
IAN T CLARK is a Board of Director who has filed 136 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing, for GH, was dated Aug 5, 2026. Across all open-market trades the lifetime net is −$40.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.94M
12
136
-$40.11M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GH | Director | 10,322 | $168.48 | $1.74M | -$20.42M | 51 | 2026-08-05 |
| OLMA | Director | 209,690 | $12.05 | $2.53M | -$7.87M | 9 | 2026-06-23 |
| CRVS | Director | — | $13.92 | — | $0 | 15 | 2026-06-15 |
| BMRN | Director | 14,490 | $63.81 | $924.6K | $0 | 2 | 2026-06-04 |
| KYTX | Director | 21,727 | $7.96 | $172.9K | $0 | 2 | 2026-05-29 |
| GDRX | Director | 100,150 | $3.68 | $368.6K | $0 | 3 | 2025-07-09 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | Director | — | $16.80 | — | $0 | 5 | 2023-06-08 |
| AGIO | Director | 6,549 | $32.27 | $211.3K | $0 | 8 | 2022-05-24 |
| Forty Seven, Inc. (FTSV) Delisted | Director | — | — | — | $0 | 2 | 2020-04-07 |
| Kite Pharma, Inc. (KITE) Delisted | Director | 7,100 | — | — | $0 | 2 | 2017-06-22 |
| TerraVia Holdings, Inc. (TVIA) Delisted | Director | — | — | — | $0 | 2 | 2017-05-23 |
| DNA | EVP-COMMERCIAL | 76 | $7.97 | $606 | -$11.81M | 14 | 2008-07-18 |
Recent Filings
136 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-05 | GH | Mixed | −5,092 | -$1.70M | EDGAR |
| 2026-08-04 | GH | Notice (144) | −14,180 | -$2.25M | EDGAR |
| 2026-06-23 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2026-06-22 | GH | Mixed | +5,092 | $0 | EDGAR |
| 2026-06-15 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2026-06-04 | BMRN | Grant (A) | +7,490 | $0 | EDGAR |
| 2026-05-29 | KYTX | Grant (A) | +5,093 | $0 | EDGAR |
| 2026-05-22 | GH | Sell (S) | −6,876 | -$735.0K | EDGAR |
| 2026-05-20 | GH | Notice (144) | −6,876 | -$735.0K | EDGAR |
| 2026-05-13 | GDRX | Notice (144) | −43,100 | -$111.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.